Jeffrey S. Aroy
Mr. Jeffrey S. Aroy is an experienced consultant, seasoned senior executive, and strong strategic thinker with more than 20 years in the industry. His consulting experience focuses on corporate and product strategy, companion diagnostics, strategic marketing, emerging markets, and M&A-oriented growth. Mr. Aroy has helped life sciences companies develop and implement growth strategies in a variety of therapeutic areas across pharmaceuticals, medical devices, and diagnostics.
Prior to joining CRA, Mr. Aroy was Managing Director at Leerink Swann where he led the professional consulting practice delivering management consulting and advisory services to pharmaceutical, biotech, medical devices, and diagnostic companies. Before that, Mr. Aroy held executive roles in two emerging diagnostics companies that were both acquired for a combined half billion dollars. He previously worked in health care consulting for such firms as IBM Global Services/The Wilkerson Group and Deloitte.
MBA, Strategic Management, The Wharton School of the University of Pennsylvania
BA, Economics, Harvard